Frank Zenke
Company: EMD Serano Inc.
Job title: Global Head DNA Damage Response Research, Translational Innovation Platform Oncology and Immuno- Oncology
Seminars:
Chair By: 1:29 pm
day: Day Two
Bachelor in Portfolio – in search of ATRi’s best partner 2:30 pm
Challenges to prioritize ATR inhibitor combinations Insights into promising DDRi combinations Relevance of genetic context for ATRi combinationsRead more
day: Day Two